UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Specific, Irreversible Inactivation of the Epidermal Growth Factor Receptor and erbB2, by a New Class of Tyrosine Kinase Inhibitor

Proceedings of the National Academy of Sciences - PNAS, 1998-09, Vol.95 (20), p.12022-12027

1998

Volltextzugriff (PDF)

Two aromatic residues regulate the response of the human oxytocin receptor to the partial agonist arginine vasopressin

FEBS letters, 1996-11, Vol.397 (2), p.201-206

1996

Volltextzugriff (PDF)

Structure−Activity Relationships for 5-Substituted 1-Phenylbenzimidazoles as Selective Inhibitors of the Platelet-Derived Growth Factor Receptor

Journal of medicinal chemistry, 1999-07, Vol.42 (13), p.2373-2382

1999

Volltextzugriff (PDF)

Pyrido[2,3-d]pyrimidin-7-one Inhibitors of Cyclin-Dependent Kinases

Journal of medicinal chemistry, 2000-11, Vol.43 (24), p.4606-4616

2000

Volltextzugriff (PDF)

Modeling of G-protein-coupled receptors: application to dopamine, adrenaline, serotonin, acetylcholine, and mammalian opsin receptors

Journal of medicinal chemistry, 1992-09, Vol.35 (19), p.3448-3462

1992

Volltextzugriff (PDF)

G-Protein Coupled Receptors: Models, Mutagenesis, and Drug Design

Journal of medicinal chemistry, 1998-07, Vol.41 (16), p.2911-2927

1998

Volltextzugriff (PDF)

The binding site of neuropeptide vasopressin V1a receptor. Evidence for a major localization within transmembrane regions

The Journal of biological chemistry, 1995-10, Vol.270 (43), p.25771-25777

1995

Volltextzugriff (PDF)

Three-dimensional models of neurotransmitter G-binding protein-coupled receptors

Molecular pharmacology, 1991-07, Vol.40 (1), p.8

1991

Volltextzugriff (PDF)

Design and synthesis of potent, orally active, inhibitors of carboxypeptidase U (TAFIa)

Bioorganic & medicinal chemistry, 2004-03, Vol.12 (5), p.1151-1175

2004

Volltextzugriff (PDF)

Tyr115 is the key residue for determining agonist selectivity in the V1a vasopressin receptor

The EMBO journal, 1995-05, Vol.14 (10), p.2176-2182

1995

Volltextzugriff (PDF)

Tyrosine Kinase Inhibitors. 11. Soluble Analogues of Pyrrolo- and Pyrazoloquinazolines as Epidermal Growth Factor Receptor Inhibitors: Synthesis, Biological Evaluation, and Modeling of the Mode of Binding

Journal of medicinal chemistry, 1997-05, Vol.40 (10), p.1519-1529

1997

Volltextzugriff (PDF)

Development of a Binding Model to Protein Tyrosine Kinases for Substituted Pyrido[2,3-d]pyrimidine Inhibitors

Journal of medicinal chemistry, 1998-05, Vol.41 (11), p.1752-1763

1998

Volltextzugriff (PDF)

The Binding Site of Neuropeptide Vasopressin V1a Receptor

The Journal of biological chemistry, 1995-10, Vol.270 (43), p.25771-25777

1995

Volltextzugriff (PDF)

This is not a G protein-coupled receptor

Trends in Pharmacological Sciences, 1993, Vol.14 (1), p.7-12

1993

Volltextzugriff (PDF)

Modelling of the binding site of the human m1 muscarinic receptor: experimental validation and refinement

Journal of computer-aided molecular design, 1997-07, Vol.11 (4), p.317-332

1997

Volltextzugriff (PDF)

Three-dimensional molecular models of the hMC1R melanocortin receptor: complexes with melanotropin peptide agonists

Drug design and discovery, 1996-12, Vol.14 (3), p.197

1996

Volltextzugriff (PDF)

Computer-aided active-site-directed modeling of the herpes simplex virus 1 and human thymidine kinase

Journal of computer-aided molecular design, 1991-10, Vol.5 (5), p.385-404

1991

Volltextzugriff (PDF)

Modelling and modification of the binding site of endothelin and other receptors

European journal of pharmacology, 1993-05, Vol.245 (3), p.203-214

1993

Volltextzugriff (PDF)

Towards understanding the role of the first extracellular loop for the binding of peptide hormones to G-protein coupled receptors

Pharmaceutica acta Helvetiae, 1995-09, Vol.70 (3), p.255-262

1995

Volltextzugriff (PDF)

Pyrido[2,3-d]pyrimidin-7-one Inhi-bitors of Cyclin-Dependent Kinases

Journal of medicinal chemistry, 2001-03, Vol.44 (6), p.1016-1016

2001

Volltextzugriff (PDF)

Investigation of receptor-ligand interactions of the Oxytocin/Vasopressin receptor family by molecular modeling and site directed mutagenesis studies

Pharmacological research, 1995, Vol.31, p.302-302

1995

Volltextzugriff (PDF)

1 – 21 von 21

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(21)
Mit Volltextzugriff
(20)

Publikationsform

Artikel
(21)

Sprache

Englisch
(21)
Japanisch
(4)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Specific, Irreversible Inactivation of the Epidermal Growth Factor Receptor and erbB2, by a New Class of Tyrosine Kinase Inhibitor

Two aromatic residues regulate the response of the human oxytocin receptor to the partial agonist arginine vasopressin

Structure−Activity Relationships for 5-Substituted 1-Phenylbenzimidazoles as Selective Inhibitors of the Platelet-Derived Growth Factor Receptor

Pyrido[2,3-d]pyrimidin-7-one Inhibitors of Cyclin-Dependent Kinases

Modeling of G-protein-coupled receptors: application to dopamine, adrenaline, serotonin, acetylcholine, and mammalian opsin receptors

G-Protein Coupled Receptors: Models, Mutagenesis, and Drug Design

The binding site of neuropeptide vasopressin V1a receptor. Evidence for a major localization within transmembrane regions

Three-dimensional models of neurotransmitter G-binding protein-coupled receptors

Design and synthesis of potent, orally active, inhibitors of carboxypeptidase U (TAFIa)

Tyr115 is the key residue for determining agonist selectivity in the V1a vasopressin receptor

Tyrosine Kinase Inhibitors. 11. Soluble Analogues of Pyrrolo- and Pyrazoloquinazolines as Epidermal Growth Factor Receptor Inhibitors: Synthesis, Biological Evaluation, and Modeling of the Mode of Binding

Development of a Binding Model to Protein Tyrosine Kinases for Substituted Pyrido[2,3-d]pyrimidine Inhibitors

The Binding Site of Neuropeptide Vasopressin V1a Receptor

This is not a G protein-coupled receptor

Modelling of the binding site of the human m1 muscarinic receptor: experimental validation and refinement

Three-dimensional molecular models of the hMC1R melanocortin receptor: complexes with melanotropin peptide agonists

Computer-aided active-site-directed modeling of the herpes simplex virus 1 and human thymidine kinase

Modelling and modification of the binding site of endothelin and other receptors

Towards understanding the role of the first extracellular loop for the binding of peptide hormones to G-protein coupled receptors

Pyrido[2,3-d]pyrimidin-7-one Inhi-bitors of Cyclin-Dependent Kinases

Investigation of receptor-ligand interactions of the Oxytocin/Vasopressin receptor family by molecular modeling and site directed mutagenesis studies

Suchergebnisse filtern